Back to Search
JEFFREY MCGINNIS, M.D.
M.D.
Adolescent Medicine (Internal Medicine) Physician
NPI: 1497704621IndividualAccepts Medicare
Specialties, Licenses & Credentials
Adolescent Medicine (Internal Medicine) PhysicianPrimary
Internal Medicine — Adolescent Medicine
Code: 207RA0000X
30432(KY)
Education
UNIVERSITY OF LOUISVILLE SCHOOL OF MEDICINE
Class of 1990
Research & Publications (20)
Discovery of 4-(benzylaminomethylene)isoquinoline-1,3-(2H,4H)-diones and 4-[(pyridylmethyl)aminomethylene]isoquinoline-1,3-(2H,4H)-diones as potent and selective inhibitors of the cyclin-dependent kinase 4.
PMID 19317452·J Med Chem·2009
7-preclinical
Synthesis, SAR study and biological evaluation of novel pyrazolo[1,5-a]pyrimidin-7-yl phenyl amides as anti-proliferative agents.
PMID 19200741·Bioorg Med Chem·2009
7-preclinical
Roundtable on expanding capacity for comparative effectiveness research in the United States: discussion took place on June 3, 2007, at the AcademyHealth Annual Research Meetingin Orlando, FL.
PMID 19208090·Health Serv Res·2009
8-other
Challenging our comfort levels: lifestyles, research, and the ongoing legacy of the Robert Wood Johnson Foundation.
PMID 19147057·Am J Prev Med·2009
8-other
Interaction of glyceraldehyde-3-phosphate dehydrogenase in the light-induced rod alpha-transducin translocation.
PMID 18028335·J Neurochem·2008
4-observational
4-(Phenylaminomethylene)isoquinoline-1,3(2H,4H)-diones as potent and selective inhibitors of the cyclin-dependent kinase 4 (CDK4).
PMID 18494457·J Med Chem·2008
8-other
Infliximab for ulcerative colitis in children and adolescents.
PMID 18645529·J Clin Gastroenterol·2008
8-other
Delay of photoreceptor degeneration in tubby mouse by sulforaphane.
PMID 17394579·J Neurochem·2007
7-preclinical
Clarification of developing and established clinical allodynia and pain-free outcomes.
PMID 17300364·Headache·2007
3-trial
Pyrazolo[1,5-a]pyrimidin-7-yl phenyl amides as novel antiproliferative agents: exploration of core and headpiece structure-activity relationships.
PMID 17275298·Bioorg Med Chem Lett·2007
8-other
Light threshold-controlled cone alpha-transducin translocation.
PMID 17591908·Invest Ophthalmol Vis Sci·2007
7-preclinical
Evaluation of a comparative pathogenesis between cancer-associated retinopathy in humans and sudden acquired retinal degeneration syndrome in dogs via diagnostic imaging and western blot analysis.
PMID 16649924·Am J Vet Res·2006
7-preclinical
Rare earth nanoparticles prevent retinal degeneration induced by intracellular peroxides.
PMID 18654167·Nat Nanotechnol·2006
7-preclinical
Bright cyclic light accelerates photoreceptor cell degeneration in tubby mice.
PMID 16216520·Neurobiol Dis·2006
7-preclinical
Validation of cyclin D1/CDK4 as an anticancer drug target in MCF-7 breast cancer cells: Effect of regulated overexpression of cyclin D1 and siRNA-mediated inhibition of endogenous cyclin D1 and CDK4 expression.
PMID 16319987·Breast Cancer Res Treat·2006
8-other
A flexible loop in tyrosine hydroxylase controls coupling of amino acid hydroxylation to tetrahydropterin oxidation.
PMID 16618490·J Mol Biol·2006
7-preclinical
Parallel synthesis and biological evaluation of 5,6,7,8-tetrahydrobenzothieno[2,3-d]pyrimidin-4(3H)-one cytotoxic agents selective for p21-deficient cells.
PMID 16143523·Bioorg Med Chem Lett·2005
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 103 COMMONWEALTH DRIVE
MT STERLING, KY 40353 - Phone
- (859) 498-7716
Quick Facts
- NPI
- 1497704621
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 36
- Publications
- 20
Are you this provider?
Claim Your Profile